Trials / Completed
CompletedNCT01417286
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This phase II trial studies how well giving accelerated radiation therapy (RT) after surgery works in treating patients with breast cancer. RT uses high energy x rays to kill tumor cells. Giving RT after surgery may kill any remaining tumor cells
Detailed description
PRIMARY OBJECTIVES: I. Freedom from local failure and freedom from regional failure. SECONDARY OBJECTIVES: I. Acute toxicity and late toxicity using previously published toxicity scales. II. To identify co-variates responsible for poor cosmetic outcome in women with reconstructed chest walls when treated with accelerated, hypofractionated radiotherapy. III. To correlate toxicity, cosmesis, and local control with molecular markers. OUTLINE: Patients undergo hypofractionated accelerated RT over 11 weekdays (for 15 elapsed days) within 21-63 days after last surgery or last course of chemotherapy. Treatment continues in the absence of disease progression or unacceptable toxicity. After completion of study treatment, patients are followed up at 2-8 weeks, every 3-6 months for 3 years, every 6-12 months for 2 years, and then annually thereafter.
Conditions
- Inflammatory Breast Cancer
- Invasive Ductal Breast Carcinoma
- Invasive Lobular Breast Carcinoma
- Mucinous Ductal Breast Carcinoma
- Papillary Ductal Breast Carcinoma
- Stage II Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Tubular Ductal Breast Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | External beam radiation therapy | Hypofractionated accelerated radiation therapy over 11 days |
Timeline
- Start date
- 2010-12-21
- Primary completion
- 2020-02-20
- Completion
- 2020-02-20
- First posted
- 2011-08-16
- Last updated
- 2023-04-20
- Results posted
- 2023-04-20
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01417286. Inclusion in this directory is not an endorsement.